Riskpilot← Back to searchSign inGet full accessVITALKOST AS
ASActiveOrg 961937434Wirgenes Vei 11, 3157 BarkåkerWholesale of other food · NACE 4638Est. 199122 employees
Revenue 2025
NOK 186,2M
+10% vs 2024
EBITDA margin
9.5%
0% vs 2024
Equity ratio
63.4%
Financial strength
Net profit 2025
NOK 13,5M
+12% vs 2024
| Revenue | NOK 186,2M | +10% |
| EBITDA | NOK 17,7M | +0% |
| Net profit | NOK 13,5M | +12% |
| Total assets | NOK 102,6M | +41% |
| Equity | NOK 65,1M | +26% |
| Employees | 22 | — |
Legal name
VITALKOST AS
Org number
961937434
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
1. mai 1991
Share capital
NOK 100 000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller daglig leder og ett styremedlem i fellesskap.
Address
Wirgenes Vei 11, 3157 Barkåker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27 563 | 48 300 | 58 126 | 65 962 | 65 479 | 69 873 | 73 555 | 72 312 | 64 285 | 75 227 | 68 870 | 73 948 | 107 112 | 113 473 | 117 506 | 131 973 | 169 086 | 186 159 |
| Staff expenses | −4 777 | −6 993 | −8 065 | −9 362 | −9 877 | −9 026 | −9 281 | −9 990 | −10 613 | −11 942 | −11 739 | −12 748 | −13 862 | −15 489 | −15 583 | −17 502 | −19 489 | −20 257 |
| EBITDA | 2 168 | 3 327 | 3 029 | 1 764 | 2 741 | 3 146 | 2 952 | 3 775 | 2 822 | 6 146 | 2 444 | 3 758 | 11 092 | 12 220 | 10 899 | 11 595 | 17 646 | 17 720 |
| Depreciation & amort. | −112 | −155 | −334 | −316 | −272 | −263 | −356 | −419 | −384 | −408 | −260 | −240 | −223 | −1 124 | −1 280 | −1 677 | −2 069 | −780 |
| EBIT | 2 056 | 3 172 | 2 695 | 1 448 | 2 469 | 2 883 | 2 596 | 3 357 | 2 438 | 5 738 | 2 184 | 3 517 | 10 869 | 11 095 | 9 619 | 9 917 | 15 577 | 16 940 |
| Net financials | 79 | 572 | 144 | −188 | −177 | −154 | −132 | −127 | −102 | −59 | −87 | −178 | −785 | 33 | −217 | −262 | 164 | 485 |
| Profit before tax | 2 136 | 3 744 | 2 839 | 1 259 | 2 292 | 2 729 | 2 464 | 3 230 | 2 336 | 5 679 | 2 097 | 3 339 | 10 084 | 11 128 | 9 402 | 9 655 | 15 741 | 17 425 |
| Tax | 653 | 1 006 | 901 | 426 | 699 | 883 | 672 | 862 | 615 | 1 445 | 562 | 686 | 1 058 | 2 472 | 2 239 | 2 191 | 3 691 | 3 962 |
| Net profit | 1 483 | 2 738 | 1 938 | 833 | 1 593 | 1 846 | 1 792 | 2 368 | 1 721 | 4 235 | 1 535 | 2 653 | 9 026 | 8 656 | 7 163 | 7 464 | 12 050 | 13 463 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8 507 | 12 968 | 12 398 | 14 650 | 15 365 | 15 382 | 16 382 | 18 849 | 18 275 | 21 605 | 21 444 | 24 216 | 38 905 | 38 806 | 57 530 | 57 269 | 72 545 | 102 624 |
| Equity | 2 987 | 3 334 | 4 192 | 3 930 | 4 531 | 6 197 | 7 551 | 9 408 | 10 379 | 11 000 | 9 438 | 11 043 | 16 269 | 24 925 | 32 088 | 39 552 | 51 602 | 65 065 |
| Long-term debt | 1 231 | 2 159 | 2 114 | 1 837 | 1 532 | 1 192 | 1 147 | 1 444 | 1 267 | 1 043 | 956 | 500 | 4 338 | 572 | 505 | 500 | 0 | 0 |
| Short-term debt | 4 288 | 7 476 | 6 093 | 8 883 | 9 302 | 7 993 | 7 684 | 7 996 | 6 629 | 9 562 | 11 050 | 12 672 | 18 298 | 13 309 | 24 937 | 17 217 | 20 942 | 37 558 |
| Total debt | 5 520 | 9 635 | 8 207 | 10 720 | 10 834 | 9 185 | 8 831 | 9 441 | 7 896 | 10 605 | 12 005 | 13 172 | 22 636 | 13 881 | 25 442 | 17 717 | 20 942 | 37 558 |
EBITDA margin
9.5%
This company
15.8%
Market median
-40% vs market
20082025
Equity ratio
63.4%
This company
38.2%
Market median
+66% vs market
20082025
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
20082025
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20082025
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
20082025
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20082025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TS Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
Nya Medicanatumin Ab | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VITALKOST AS 
CORPUS MEDICUS ASBoard members of VITALKOST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thor Steinar Solvang | Chief Executive Officer | 0 companies |
| Simon Gustav Seved Petren | Chairman | 0 companies |
| Ulrika Ann-Britt Albers | Chairman | 0 companies |
| Jan Peter Hencz | Chairman | 0 companies |
| Johan Christer Lennartsson | Board of Directors | 0 companies |
| Noel Christofer Peter Abdayem | Board of Directors | 0 companies |
| Bengt Peter Carlsson | Board of Directors | 0 companies |